Progesteron
PreclinicalSmall molecule
Progesteron is one of 30 small molecule programs targeting Miscarriage. It is currently in Preclinical.
1
Indications
2
Total Trials
0
Active Trials
29
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
37 competitors in Miscarriage
#DrugCompanyPhaseTrials
1Cytotec
PfizerApproved
Femara
NovartisApproved
Bayer Aspirin
BayerApproved
Glucophage
EMD SeronoApproved
Heparin Sodium
BBaxter Healthcare Corporation
Approved
Deltasone
PPfizer's Upjohn has merged with Mylan to form Viatris Inc.
Approved
Intralipid
AstraZenecaApproved
Plavix
SanofiPhase 3
Estrace
Novo NordiskPhase 3
Gynorest
SSolvay Pharmaceuticals
Phase 3
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Progesteron. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- MMinia University